154 related articles for article (PubMed ID: 31248705)
1. Tongue surface model can predict radiation tongue mucositis due to intensity-modulated radiation therapy for head and neck cancer.
Musha A; Fukata K; Saitoh JI; Shirai K; Abe T; Mizukami T; Kawashima M; Yokoo S; Chikamatsu K; Ohno T; Nakano T
Int J Oral Maxillofac Surg; 2020 Jan; 49(1):44-50. PubMed ID: 31248705
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Acute Radiation Mucositis using an Oral Mucosal Dose Surface Model in Carbon Ion Radiotherapy for Head and Neck Tumors.
Musha A; Shimada H; Shirai K; Saitoh J; Yokoo S; Chikamatsu K; Ohno T; Nakano T
PLoS One; 2015; 10(10):e0141734. PubMed ID: 26512725
[TBL] [Abstract][Full Text] [Related]
3. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
[TBL] [Abstract][Full Text] [Related]
4. Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag reflex, or discomfort during intensity-modulated radiation therapy.
Kil WJ; Kulasekere C; Derrwaldt R; Bugno J; Hatch C
Oncotarget; 2016 Aug; 7(33):53029-53036. PubMed ID: 27447973
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of optimizing intensity-modulated radiation therapy plans based on measured mucosal dose adjacent to dental fillings and toxicity outcomes.
Seol SW; Aggarwal S; von Eyben R; Wang Z; Chan C; Say C; Xing L; Hara W; Yang Y; Le QT
J Appl Clin Med Phys; 2018 Sep; 19(5):444-452. PubMed ID: 29984915
[TBL] [Abstract][Full Text] [Related]
6. Radiobiological modeling of radiation-induced acute mucosal toxicity (oral mucositis and pharyngeal mucositis): A single-institutional study of head-and-neck carcinoma.
Singh B; Singh G; Oinam AS; Kumar V; Vashistha R; Sidhu MS; Singh M
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0-S1715. PubMed ID: 37147947
[TBL] [Abstract][Full Text] [Related]
7. Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study.
Wang ZH; Zhang SZ; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Laryngoscope; 2012 Feb; 122(2):291-8. PubMed ID: 22253016
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
9. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
10. [Intensity-modulated radiation therapy for head and neck cancers with bilateral irradiation of the neck : preliminary results].
Lapeyre M; Marchesi V; Mege A; Aletti P; Graff P; Racadot S; Noel A; Marchal C
Cancer Radiother; 2004 Jun; 8(3):134-47. PubMed ID: 15217581
[TBL] [Abstract][Full Text] [Related]
11. Relationship of protein and calorie intake to the severity of oral mucositis in patients with head and neck cancer receiving radiation therapy.
Zahn KL; Wong G; Bedrick EJ; Poston DG; Schroeder TM; Bauman JE
Head Neck; 2012 May; 34(5):655-62. PubMed ID: 21692134
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost (IMRT-SIB) in head and neck squamous cell carcinoma in patients not suitable for chemo-radiotherapy.
Rastogi M; Sapru S; Gupta P; Gandhi AK; Mishra SP; Srivastava AK; Khurana R; Hadi R; Sahni K; S F
Oral Oncol; 2017 Apr; 67():10-16. PubMed ID: 28351562
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
[TBL] [Abstract][Full Text] [Related]
14. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer.
Ki Y; Kim W; Nam J; Kim D; Park D; Kim D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):393-8. PubMed ID: 19362778
[TBL] [Abstract][Full Text] [Related]
16. Intensity modulated radiation therapy and oral mucosa sparing in Head and neck cancer patients: A systematic review on behalf of Italian Association of Radiation Oncology - Head and neck working group.
De Sanctis V; Merlotti A; De Felice F; Trignani M; Dell'Oca I; Lastrucci L; Molteni M; Frakulli R; Bunkheila F; Bacigalupo A; Paiar F
Crit Rev Oncol Hematol; 2019 Jul; 139():24-30. PubMed ID: 31112879
[TBL] [Abstract][Full Text] [Related]
17. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
19. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.
Narayan S; Lehmann J; Coleman MA; Vaughan A; Yang CC; Enepekides D; Farwell G; Purdy JA; Laredo G; Nolan K; Pearson FS; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):756-62. PubMed ID: 18417299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
